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Objective: Aortic inflammation and the genes that regulate the immune response play an important role in abdominal
aortic aneurysm pathogenesis. However, the modulating effects of such genetic and other environmental factors on the
severity on aneurysm inflammation is not known. The objective of this study was to determine the influence of the human
leukocyte antigen (HLA) class II genes, gender, and environmental factors on degree of abdominal aortic aneurysm tissue
inflammation.
Methods: Aneurysm specimens were obtained at the time of operation from 96 consecutive patients who underwent
abdominal aortic aneurysm repair and were graded for degree of histologic inflammation. Multivariate analysis was used
to determine the association of genetic and environmental factors with degree of inflammation and to determine the
HLA-associated disease risk for aneurysm.
Results: Active cigarette smoking and female gender were independently associated with high-grade tissue inflammation
identified histologically (odds ratio [OR], confidence interval [CI]: 5.6, 1.6 to 19.3; and 6.0, 1.4 to 26.2, respectively),
and a specific HLA allele (DR B1*01) was inversely associated with inflammation (OR, CI: 0.2, 0.04 to 0.7). Overall, the
HLA-DR B1*02 and B1*04 alleles were significantly associated with disease risk, more than doubling risk for abdominal
aortic aneurysm (OR, CI: 2.5, 1.4 to 4.3; and 2.1, 1.2 to 3.7, respectively).
Conclusion: Active cigarette smoking and female gender are significant disease-modulating factors associated with
increased abdominal aortic aneurysm inflammation. In addition, the HLA class II immune response genes possess both
disease modulating and disease risk properties, which may be useful in early aneurysm detection and surveillance. (J Vasc
Surg 2002;35:988-93.)
Abdominal aortic aneurysms are a disease of the elderly
and represent a frequent cause of death in those older than
age 65 years.1-3 Aneurysms represent a challenge in an
aging population because they are difficult to detect with
physical examination and often remain occult.4 Remark-
ably, three fourths of patients with ruptured aneurysms are
unaware of their disease until the date of rupture.4-7 At
present, ultrasound screening programs of the abdominal
aorta are not widely accepted, and such programs often
exclude women and are based on poorly understood clini-
cal risk factors with no established genetic markers of
disease risk.
The importance of gender in the development of ab-
dominal aortic aneurysms is underscored by the fact that
aneurysms have a more aggressive clinical course in women
than in men.8,9 Although aneurysms are a predominately
male disease, a disproportionate number of women are seen
with rupture. Furthermore, elective and emergent opera-
tive mortality rates are higher in women than in men.9,10
Cigarette smoking, the most significant environmental fac-
tor relating to abdominal aortic aneurysms, is associated
with both aneurysm expansion rate and rupture.11-16 De-
spite these clinical observations, the mechanisms through
which female gender and cigarette smoking influence ab-
dominal aortic aneurysm formation are not known.
Local immune responses within the aorta are important
in aneurysm pathogenesis and represent a source of cyto-
kines that weaken the aorta through breakdown of smooth
muscle cells and structural proteins. Furthermore, inflam-
mation within the wall of the aorta is present throughout
aneurysm development and is directly related to aneurysm
expansion and size.17-25 The human leukocyte antigen
(HLA) class II genes regulate inflammation, and specific
alleles have been identified as factors in aneurysm develop-
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ment. However, the disease risk for aneurysm associated
with the HLA class II genes is not well quantified, and the
modulating effects of the immune response genes on aneu-
rysm inflammation are not known.26-28 The purpose of this
study was to determine the association of gender, cigarette
smoking, and HLA type with the degree of local abdominal
aortic aneurysm inflammation and to establish the disease
risk for abdominal aortic aneurysms associated with HLA
class II genes.
METHODS
HLA class II genotyping was performed in 142 consec-
utive patients who underwent elective abdominal aortic
aneurysm repair at the Mayo Clinic. All patients in the
cohort were white, which reflects both the racial distribu-
tion of the disease and the geographic location of the study.
Full thickness sections from the proximal anterolateral por-
tion of the aneurysm were available for histologic study in
96 patients from the cohort. Procurement of tissue at the
time of aneurysm repair was at the discretion of the surgeon
and did not interfere with conduct of the operation. Tissue
was not obtained in 20 patients because of surgeon discre-
tion, and 26 specimens were excluded because they were
not full-thickness sections through the aneurysm wall.
Cross sections of aneurysm wall were stained with
hematoxylin and eosin and graded for degree of inflamma-
tion by one pathologist without knowledge of HLA or
clinical data. All elements of the aortic wall (intima, media,
and adventitia) were examined for the presence and severity
of inflammation and graded as either low-grade or high-
grade inflammation. Low-grade inflammation included
those specimens with no inflammatory cells (lymphocytes,
macrophages, or plasma cells) or with only scattered, ad-
ventitial inflammatory cells without aortic wall thickening
(2.0 mm; Fig 1A). High-grade inflammation consisted of
specimens with confluent, adventitial inflammatory cells
(lymphocytes, macrophages, or plasma cells) or germinal
centers, with fibrous aortic wall thickening (2.0 mm; Fig
1B).
Genetic comparison. Blood samples from 118 ethni-
cally matched individuals with no known aortic, cardiovas-
cular, or autoimmune disease were obtained for HLA class
II genotyping and comparison with aneurysm patients (n
142). DNA was extracted from whole blood of patients and
control subjects with the DNA Isolation Kit for Mamma-
lian Blood (Roche Molecular Biochemicals, Boehringer
Mannheim, Indianapolis, Ind) and the QIAamp Blood Kit
(Qiagen, Chatsworth, Calif) according to manufacturer
procedures. HLA-DR B1 genotyping was performed with a
Micro SSP HLA DRB kit (One Lambda, Canoga Park,
Calif). Trays provided sequence-specific oligonucleotide
primers for the 12 major allelic variants at the HLA-DR B1
locus. Matched primer pairs resulted in the amplification of
target sequences. Polymerase chain reaction was performed
in a 9600-thermal cycler (PE Biosystems, Foster City,
Calif) with the following conditions: denaturation at 96°C
for 130 seconds, annealing at 63°C for 60 seconds; fol-
lowed by 9 cycles of 96°C for 10 seconds and 63°C for 60
seconds; then 20 cycles of 96°C for 10 seconds, 59°C for
50 seconds, and 72°C for 30 seconds. Amplified DNA was
separated with agarose gel electrophoresis and visualized
with ethidium bromide and ultraviolet light.
Clinical factors. Data were abstracted from the med-
ical records of all 142 patients. Smoking status was catego-
Fig 1. A, Low-grade abdominal aortic aneurysm inflammation. (Hematoxylin and eosin:3, upper panel;25, lower
panel). B, High-grade abdominal aortic aneurysm inflammation. Lower panel shows germinal centers (left) and
lymphoid aggregates surrounded by chronic inflammatory cells set in fibrous desmoplastic stroma. (Hematoxylin and
eosin: 3, upper panel; 25, lower panel).
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rized by patient report as current, former, or never. Dura-
tion of smoking was estimated in a pack-years calculation.
Statistical analysis. The frequency of the 12 major
alleles in the study cohort (n 142) was compared with the
frequency in controls (n  118), initially with univariate
logistic regression analysis. Alleles that were significantly
enhanced (P  .05) or that showed a trend towards en-
hancement (P  .05 to .09) in univariate analysis results
were identified as possible risk alleles. Alleles were deter-
mined to be randomly distributed if their P values were
more than .10. The risk alleles identified with univariate
analysis were placed into a stepwise logistic regression
analysis to develop a multivariate disease-risk model re-
ported as odds ratios (ORs) and 95% confidence intervals
(CIs).
Univariate logistic regression was performed to deter-
mine the association of clinical factors (gender, smoking
status, pack-years smoked, aneurysm size, age, and family
history of aortic aneurysm) with either low-grade or high-
grade aneurysm inflammation (n 96). Patient HLA types
then were added with the clinical data, and a multivariate
logistic regression model was established to determine any
HLA associations with degree of inflammation. The possi-
bility of two-way interactions in the multivariate models
reported was investigated. Institutional review board ap-
proval was granted and patient consent was obtained for
the genotyping, tissue procurement, and clinical data ab-
straction necessary for this study.
RESULTS
Tissue study. Among the 96 patients who had histo-
logic grading of abdominal aortic aneurysm inflammation,
the median age was 71 years (range, 46 to 90 years) and
males predominated (n  80; 83%; Table I). All of the
female patients in the tissue study were postmenopausal.
Eighty-four patients (88%) were current or former smokers,
and 20 patients (21%) had a family history of aortic aneu-
rysm. The median aneurysm diameter was 5.9 cm (range, 4
to 10 cm).
Univariate logistic regression results determined female
gender and current smoking to be independently associ-
ated with high-grade aneurysm inflammation (Table II).
No other clinical factors, including pack-years smoked,
aneurysm size, patient age, or family history of aortic aneu-
rysm, were associated with severity of tissue inflammation.
Only two of the 16 women (12%) who had aortic aneurysm
tissue grading were undergoing estrogen replacement ther-
apy. One was a current smoker found to have high-grade
aortic aneurysm inflammation, and the other was a former
smoker found to have low-grade inflammation.
A multivariate logistic regression model that included
the HLA genotypes and clinical data showed that a specific
HLA class II allele, B1*01, was associated inversely with
aneurysm inflammation (OR, 0.2; CI, 0.04 to 0.7; Fig 2).
In this model of genetic and environmental factors, female
gender (OR, 6.0; CI, 1.4 to 26.2) and current smoking
(OR, 5.6; CI, 1.6 to 19.3) were again shown to be inde-
pendently associated with high-grade aortic inflammation.
These factors had no two-way interaction, and the overall
model P value was less than .001.
Genetic study. The median age of the 142 patients
who underwent HLA genotyping was 71 years (range, 42
to 90 years), and males predominated (n 119; 84%; Table
I). One hundred twenty-four patients (87%) were current
or former smokers. Twenty-eight patients (20%) reported a
family history of aortic aneurysms. The median aneurysm
diameter was 6.0 cm (range, 3.5 to 10 cm).
The HLA-DR B1*02 (42% versus 25%; P  .01) and
B1*04 (35% versus 25%; P  .08) alleles were more com-
mon in the aneurysm cohort compared with controls and
were identified as risk alleles (Fig 3). In contrast, the B1*01
(18% versus 27%; P  .09), B1*08 (6% versus 14%; P 
.04), and B1*14 (1% versus 10%; P  .01) alleles were
diminished in the aneurysm cohort compared with con-
trols. The seven remaining major alleles at the HLA-DR B1
locus were distributed evenly among the study cohort and
controls (P .10). A multivariate, disease risk model
showed the B1*02 (OR, 2.5; CI, 1.4 to 4.3) and B1*04
(OR, 2.1; CI, 1.2 to 3.7) alleles as independently associated
with abdominal aortic aneurysm (Fig 4; overall model P
value  .007). There were no two-way interactions be-
tween these alleles, suggesting the OR in a B1*02/04
heterozygous case to be additive (near 4.5 fold).
Table I. Characteristics of patients with abdominal aortic
aneurysm who underwent human leukocyte antigen
genotyping and aneurysm tissue study
Charcteristic
Genetic study
(n  142)
Tissue study
(n  96)
Age (y)* 71 (42-90) 71 (46-90)
Gender
Male 119 (84%) 80 (83%)
Female 23 (16%) 16 (17%)
Smoking pattern
Current 39 (28%) 24 (25%)
Former 85 (60%) 60 (63%)
Never 18 (12%) 12 (13%)
Family history of aneurysm 28 (20%) 20 (21%)
Aneurysm diameter (cm)* 6.0 (3.5-10.0) 5.9 (4.0-10.0)
*Median (range).
Table II. Univariate logistic regression analysis results of
clinical factor association with high-grade aortic aneurysm
tissue inflammation (n  96)
Clinical factor
Odds ratio
(95% confidence interval)
P
value
Female gender 5.9 (1.5, 22.1) .009
Current smoking 4.4 (1.6, 12.5) .005
Pack-years smoked 1.0 (0.9, 1.01) .41
Aneurysm size 1.1 (0.8, 1.6) .53
Age 0.9 (0.6, 1.5) .76
Family history of aneurysm 1.0 (0.4, 2.8) .92
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DISCUSSION
This study shows for the first time that active cigarette
smoking and female gender are independently associated
with severity of local aortic aneurysm inflammation. In
addition, these findings show the B1*01 allele, a specific
genetic factor, to be negatively associated with local aortic
aneurysm inflammation. Finally, this study quantifies sig-
nificant disease risk for abdominal aortic aneurysm associ-
ated with genes within the HLA class II region of chromo-
some 6.
Genetic studies. These findings support results from
earlier studies that identified the B1*02 (which includes the
B1*15 and B1*16 alleles) and B1*04 alleles as important in
white, Japanese, and black patients with abdominal aortic
aneurysms.26-28 This study extends previous observations
by providing a quantitative assessment of the contribution
of HLA alleles to disease risk for abdominal aortic aneurysm
in a large cohort of patients.
Cigarette smoking, female gender, and aortic in-
flammation. This study provides new data that active cig-
arette smoking is associated with increased inflammation
within the wall of abdominal aortic aneurysms. This finding
is consistent with the premise that smoking affects the aorta
through immune-mediated pathways and provides insight
into the increased expansion and rupture rates observed in
patients with aneurysm who smoke.11,12,29-32 Importantly,
neither former smoking nor pack-years smoked were asso-
ciated with increased aortic inflammation, suggesting an
acute and not a cumulative effect. This observation under-
scores the importance of smoking cessation and supports
recent studies that have found longer periods of cessation
to correlate with decreasing risk of aneurysm.15,16
The association of female gender with high-grade an-
eurysm tissue inflammation, independent of smoking or
HLA status, has not been reported. These findings may
reflect women’s overall susceptibility to immune-related
arterial diseases, such as giant cell arteritis and Takayasu’s
disease.33,34 However, these data also provide a possible
explanation for the aggressive course of aneurysms in
women, specifically pertaining to the greater risk of aneu-
rysm rupture in women compared with men.8-11 Further-
more, these findings raise important questions regarding
the influence of estrogen replacement therapy on the mag-
nitude of aneurysm inflammation and the influence of
estrogen on the aggressive course of aneurysms in post-
menopausal women. The current findings suggest that
women should be included in aneurysm early detection
efforts, especially older women or women with other ge-
netic or environmental risk factors.
Human leukocyte antigen DR B1*01 as a protec-
tive allele. An important new finding from this study is
that a specific HLA allele protects against local aortic in-
flammation. This observation suggests that antigen bound
to HLA molecules in B1*01 individuals may dilute or
divert proinflammatory reactions within the aorta. The
overall antiinflammatory effect of this allele may be signifi-
cant enough to reduce the risk for aortic aneurysm because
B1*01 individuals were relatively underrepresented in the
study cohort (Fig 3). Interestingly, underexpression of the
B1*01 allele is also observed in patients with giant cell
Fig 2. Multivariate logistic regression analysis results show association of genetic and environmental factors with
high-grade aortic inflammation. DR,; CI, confidence interval.
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arteritis, another inflammatory arterial disease.33 This
observation in separate analyses of different diseases
suggests a genuine role of this allele in modulating
arterial wall inflammation.
Disease risk versus disease modulation. Surpris-
ingly, the primary HLA risk alleles for abdominal aortic
aneurysm (B1*02 and B1*04) did not influence tissue
inflammation as measured in this study. These findings
suggest that polymorphic HLA molecules influence aneu-
rysm pathogenesis through different mechanisms or at
different phases of pathogenesis (ie, disease initiation versus
disease modulation). HLA molecules selectively bind and
present antigenic peptides to elicit and amplify adaptive
immune responses.26 The distinct association of the B1*02
and B1*04 alleles with disease risk and the B1*01 allele
with disease modulation suggests an interesting model in
which antigen-dependent mechanisms are relevant at sev-
eral points in aneurysm pathogenesis.
Study limitations. HLA risk was examined only in
patients who underwent elective abdominal aortic aneu-
rysm repair. The role of these genes as factors in the more
commonly encountered small abdominal aortic aneurysm
and their potential role in predicting aneurysm expansion
or rupture remains to be determined. In addition, the
methods used to grade inflammation in this study were
strictly observational. However, this common histologic
approach revealed strong clinicopathologic associations
without the need for advanced molecular techniques or a
larger sample size. Finally, the abdominal aorta was not
specifically imaged in the control group, which makes it
possible that persons in this group had abdominal aortic
aneurysms. In this unlikely case, the HLA risk of such
persons would be the same as the actual study cohort and
their removal from the control group would only increase
or strengthen the reported ORs.
Clinical implications. In spite of these limitations,
this study has valuable implications for the management of
abdominal aortic aneurysms relating to early detection and
risk factor modification. Specifically, more than doubling of
the disease risk for aneurysms in B1*02 and B1*04
individuals is significant enough to consider these genetic
markers for clinical screening purposes. Families of B1*02
and B1*04 donors may also be considered kindreds at
higher disease risk for abdominal aoritic aneurysm.
The association of female gender with high-grade an-
eurysm inflammation combined with the known clinical
course of aneurysms in women suggests that women should
be included in early aneurysm detection programs. The
results of this study also emphasize the importance of
smoking cessation in patients at genetic risk for, or with
known, abdominal aortic aneurysms. An aggressive smok-
ing cessation program in patients with aneurysms is likely to
be cost-effective because smoking increases aneurysm ex-
pansion and therefore the likelihood of complications or
the need for operation.11,12
CONCLUSION
This study provides quantitative data on specific ge-
netic risk factors for abdominal aortic aneurysms within the
HLA class II immune response genes. These genetic factors
represent biomarkers that may advance aortic screening and
early aneurysm detection programs. In addition, this study
shows that female gender is associated with increased an-
eurysm inflammation, providing histologic evidence for the
aggressive clincal behavior of aneurysms in women. Finally,
this study emphasizes the need for assertive smoking cessa-
tion efforts to reduce immune-mediated destruction of the
aorta in patients at genetic risk for, or with known, abdom-
inal aortic aneurysms.
Fig 3. Univariate logistic regression analysis results show distribution of five nonrandom (P  .10) human leukocyte
antigen DR B1 alleles in patients with abdominal aortic aneurysms versus controls. Compared with controls, DR B1*02 and
DR B1*04 alleles are enhanced in aneurysm cohort and DR B1*01, DR B1*08, and DR B1*14 alleles are diminished.
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